Science Panel urges caution over animal-to-human transplants
Daily Yomiuri On-Line, Japan
Sep 24, 2000
A Health and Welfare Ministry panel has decided to urge
medical institutions nationwide to adopt a cautious approach toward plans
to conduct treatment and other medical activities that involve transplants
of internal organs and tissue from animals to humans.
The recommendation's to be issued by a subcommittee of
the ministry's Health Sciences Council, which made the decision Friday,
follows a set of strict guidelines on what is known as xenotransplantation
announced by the U.S. Food and Drug Administration in May.
The FDA guidelines stipulate that patients given animal
organs or tissue be under medical observation for the rest of their lives,
and that blood serums of the donor animals be kept for 50 years after
transplantation.
If medical institutions actually follow such strict guidelines,
however, clinical application of animal-to-human transplants will become
virtually impossible in Japan, medical sources warned.
At Friday's panel meeting, reports were given on various
research cases of animal-to-human transplants and attempts to control
them both in and out of Japan. According to one report, Okayama University's
medical ethics council recently approved an experiment in which a capsule
of rat cells would be implanted into the brain of a patient suffering
from Parkinson's disease.
Some panel members reportedly expressed concerns over
the dangers of animal-to-human transplants, from which infection by an
unknown virus has already beenreported abroad.
In light of such concerns, the panel approved a proposal
made by Fumimaro Takahisa, chairman of the panel and president of Jichi
Medical School, to advise the medical institutions to exercise the utmost
care in such transplants.
Copyright 2000 The Yomiuri Shimbun |